Recent Updates
Recently added Catalysts
IMMP Negative Sentiment Score: 25/100

IMMUTEP LIMITED (IMMP) INVESTOR ALERT Investors With Large Losses in Immutep Limited Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Key Takeaway: Bernstein Liebhard LLP has initiated a securities class action lawsuit on behalf of investors who purchased American Depositary Receipts of Immutep Limited between March 24, 2025, and March 12, 2026. The lawsuit accuses the company of making false and misleading statements about its business and financial health, which led to inflated stock prices. When the actual situation was disclosed, investors experienced substantial financial losses. Affected shareholders are encouraged to contact the law firm to discuss their rights and possible participation in the class action.

Market Sentiment Analysis

CONCERNS & RISKS

  • A securities class action lawsuit has been filed against Immutep Limited, indicating significant investor dissatisfaction.
  • The lawsuit alleges that the company's representatives made materially false and misleading statements regarding business operations and financial stability.
  • Investors reportedly suffered significant losses when the truth behind the company's inflated stock prices was revealed.

Full Press Release Details

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the American Depositary Receipts (“ADRs”) of Immutep Limited (“Immutep” or the “Company”) (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026, inclusive.
If you purchased or acquired Immutep ADRs, and/or would like to discuss your legal rights and options please visit Immutep Limited Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
If you wish to serve as lead plaintiff for the Class, you must file papers by July 6, 2026. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
The lawsuit alleges that defendants made materially false and misleading statements and omissions regarding the Company’s business operations, growth prospects, and financial stability. As a result of these alleged misrepresentations, Immutep ADRs traded at artificially inflated prices during the Class Period. When the truth was disclosed, investors allegedly suffered significant losses.
About Bernstein Liebhard:
Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.
ATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Investor Relations Manager
Bernstein Liebhard LLP

Tags

immutep class action

Frequently Asked Questions

What is the Immutep securities class action about?

The lawsuit involves claims that defendants made false statements about Immutep's business and finances.

Who can participate in the Immutep class action lawsuit?

Investors who bought Immutep ADRs between March 24, 2025, and March 12, 2026, can participate.

How do I become the lead plaintiff in the lawsuit?

To serve as lead plaintiff, you must file paperwork by July 6, 2026.

Is there a fee to participate in the class action?

No, all representation is on a contingency fee basis; shareholders pay no fees.

What happens if I take no action in the lawsuit?

If you don't act, you can remain an absent class member without taking part.

Last updated: May 7, 2026